Results underscore clinical utility of novel circulating tumor DNA assay to detect disease recurrence Clinical Genomics, a private company developing innovative diagnostic tools for colorectal cancer, ...

PITTSBURGH--(BUSINESS WIRE)--RedPath Integrated Pathology, Inc., a leader in molecular diagnostics, announced the launch of a new, patent-pending, customized test to accurately measure ...

Trends in surveillance testing after treatment for colorectal cancer remained relatively stable recently, and patients who overutilized surveillance measures had quicker recurrence detection but ...

The Consumer Electronics Association said its Technology and Standards committees are revising and developing standards for home and car audio testing methods. The Mobile Electronics Committee plans ...

Arlington, Va. — The Consumer Electronics Association’s (CEA) antennas committee today announced revisions to its antenna testing standard to include the testing of self-adjusting “smart” antennas.

A cohort of 250 patients diagnosed with stage II or III CRC in 2004 and alive 42 months after diagnosis was identified from health administrative data in Manitoba, Canada. Colonoscopy, liver imaging, ...

These markers are most helpful when someone already has a diagnosed cancer — to track treatment response or detect recurrence ...

Retrospective health care claims database analysis of direct medical costs of newly diagnosed patients (pts) with hepatocellular carcinoma (HCC) in the United States. Background: Relapse after ...

Carcinoembryonic antigen (CEA) testing market was valued at USD 2.36 billion by 2019, growing with 6.4% CAGR during the forecast period, 2020-2026. The dynamic nature of business environment in the ...

Kudos to the Consumer Electronics Association (CEA) for providing DTV set manufacturers a set of software to test Digital Television Closed Captioning (DTVCC). The CEA released the software today on ...